Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.69 is 74% below its 5-year average of 22.18, near the low end of its 5-year range (4.92–85.32).
As of the fiscal period ended Tuesday, June 30, 2026. 11.30% below its 12-month average of 6.41.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.69.
CURRENT RATIO
5.69
CURRENT RATIO AVG TTM
6.41
CURRENT RATIO AVG 3Y
13.86
CURRENT RATIO AVG 5Y
22.18
CURRENT RATIO AVG 10Y
12.31
CURRENT RATIO AVG 15Y
7.59
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.30%
CURRENT VS 3Y AVG
-58.95%
CURRENT VS 5Y AVG
-74.35%
CURRENT VS 10Y AVG
-53.79%
CURRENT VS 15Y AVG
-25.03%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.08
median of 391 covered companies
CURRENT VS SECTOR MEDIAN
+84.70%
vs the sector median at left
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Current Ratio
5.69
TTM Avg
6.41
3Y Avg
13.86
5Y Avg
22.18
Market Cap
$20.93M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$18.77M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$30.92M
Current Ratio
5.81
TTM Avg
22.07
3Y Avg
14.94
5Y Avg
12.78
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | 5.69 | 6.41 | 13.86 | 22.18 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.07 | 0.37 | 0.39 | 0.82 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 1.13 | 1.19 | 1.11 | 1.05 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 1.25 | 1.72 | 2.15 | 2.15 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 5.12 | 5.39 | 5.72 | 7.97 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 1.05 | 0.99 | 1.52 | 1.43 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.20 | 0.34 | 6.34 | 6.11 |
| CervoMed Inc. (CRVO)vs › | $30.65M | 8.57 | 7.97 | 5.03 | 6.79 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 5.81 | 22.07 | 14.94 | 12.78 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 1.29 | 1.73 | 1.92 | 1.90 |
Current Ratio
5.69
Quick Ratio
5.69
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.69 |
| 2026-03-31 | 4.92 |
| 2025-12-31 | 5.53 |
| 2025-09-30 | 6.77 |
| 2025-06-30 | 9.17 |
| 2025-03-31 | 12.67 |
| 2024-12-31 | 14.99 |
| 2024-09-30 | 13.30 |
| 2024-06-30 | 14.35 |
| 2024-03-31 | 16.34 |
| 2023-12-31 | 17.61 |
| 2023-09-30 | 28.35 |
| 2023-06-30 | 30.48 |
| 2023-03-31 | 37.66 |
| 2022-12-31 | 21.23 |
| 2022-09-30 | 43.02 |
| 2022-06-30 | 35.18 |
| 2022-03-31 | 58.94 |
| 2021-12-31 | 45.18 |
| 2021-09-30 | 85.32 |
| 2021-06-30 | 81.19 |
| 2021-03-31 | 102.26 |
| 2020-12-31 | 2.73 |
| 2020-09-30 | 7.23 |
| 2020-06-30 | 5.51 |
| 2020-03-31 | 12.85 |
| 2019-12-31 | 10.83 |
| 2019-09-30 | 10.48 |
| 2019-06-30 | 17.80 |
| 2019-03-31 | 13.94 |
| 2018-12-31 | 3.96 |
| 2018-09-30 | 3.92 |
| 2018-06-30 | 5.45 |
| 2018-03-31 | 7.96 |
| 2017-12-31 | 6.45 |
| 2017-09-30 | 2.75 |
| 2017-06-30 | 2.09 |
| 2017-03-31 | 1.96 |
| 2016-12-31 | 3.11 |
| 2016-09-30 | 5.28 |
| 2016-06-30 | 1.66 |
| 2016-03-31 | 2.55 |
| 2015-12-31 | 1.72 |
| 2015-09-30 | 2.90 |
| 2015-06-30 | 4.03 |
| 2015-03-31 | 3.26 |
| 2014-12-31 | 4.13 |
| 2014-09-30 | 7.61 |
| 2014-06-30 | 9.39 |
| 2014-03-31 | 16.36 |
| 2013-12-31 | 4.80 |
| 2013-09-30 | 4.43 |
| 2013-06-30 | 3.02 |
| 2013-03-31 | 2.15 |
| 2012-12-31 | 1.21 |
| 2012-09-30 | 0.39 |
| 2012-06-30 | 0.50 |
| 2012-03-31 | 1.56 |
| 2011-12-31 | 1.95 |
| 2011-09-30 | 2.90 |
| 2011-06-30 | 0.00 |
| 2011-03-31 | 0.00 |
| 2010-12-31 | 0.01 |
| 2010-09-30 | 0.06 |
| 2010-06-30 | 0.41 |
| 2009-09-30 | 0.00 |
